In sum, our results illuminate a mechanism by which the PPM1D phosphatase coordinately opposes two major stress signaling pathways, the p53 network and the IRS, to promote the survival of cancer cells, with clear implications for the development of p53 reactivation strategies in the clinic. This evidence concerns the gene TP53 and cancer.